Myasthenia Gravis Disease Market Research Report: Strategic Insights and Industry Prospects
Valued at USD 2.60 billion in 2024, the myasthenia gravis disease market is projected to reach USD 2.83 billion in 2025 and USD 6.19 billion by 2034, growing at a CAGR of 9.1% during the forecast period 2025–2034. Growing awareness, the expansion of clinical trials, and rising demand for personalized medicine are notable contributors. Leading participants include Alexion Pharmaceuticals...
0 التعليقات 0 المشاركات 31 مشاهدة 0 معاينة